slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 87,391-87,420
Pages 3,225
Rows per page 30
Component
87,391-87,420 of 96,741
09
The slide uses a spiral diagram to represent the iterative nature of their AI-driven drug discovery process.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
24
The pie chart labels are slightly ambiguous; the 26% slice is labeled 'Immuno-oncology', 39% 'Oncology', and 35% 'Autoimmunity and Inflammation'.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
04
The slide uses a two-column structure to highlight market reach across both brands and retailers.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a donut chart to visualize the revenue split between the two segments.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
09
The slide uses a dual-table layout to categorize clients into 'Brands' and 'Retailers', emphasizing long-term tenure (10-25+ years) and cross-service adoption.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
18
Uses a four-column layout to define strategic financial pillars.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
05
Advantage Solutions | Results Presentation Deck | 13 slidesAdvantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · OverviewLoop · So What Cascade1 hit
09
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the difficulty of treatment compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
The slide outlines a two-part clinical trial structure with specific cohorts and patient criteria.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
19
Includes statistical significance markers and clinical guideline thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
20
Includes statistical significance (p-values) and MCID reference lines for GMFM-E.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
21
The slide uses a heatmap to visualize individual patient outcomes, a common technique in clinical trial reporting.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
22
Data presented as n (%).Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
26
Includes footnotes detailing cash equivalents and share breakdown.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Impact and Next Steps1 hit
28
The slide uses a process flow diagram to contrast intracellular metabolism with plasma-based enzymatic intervention.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
38
The table highlights specific clinical improvements for six individual patients, emphasizing normalization of mobility.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
14
Includes a callout regarding COVID-19 impact on 2020 sales.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations Beat · Evidence & Proof1 hit
24
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.Alkermes | Investor Presentation Deck | 32 slides · Alkermes
Research note Investor relations 1 hit
05
Allbirds | Investor Presentation Deck | 14 slidesAllbirds | Investor Presentation Deck | 14 slides · Allbirds
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
09
The slide uses a color-coded column layout to contrast fund performance against benchmarks, emphasizing historical outperformance.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
36
The chart uses a shaded region to denote the GFC period (roughly 2Q08 to 1Q09).Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
38
Includes a call-to-action button for an external document and a preview of a secondary slide.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
05
Includes B-Corp certification logo.AppHarvest | Results Presentation Deck | 13 slides · AppHarvest
Conference presentation Investor relations 1 hit
13
The slide displays 8 individual patient case studies (Pt 46, 51, 52, 53, 56, 58, 59, 60, 61).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
20
The slide uses a three-column layout to explain the scientific basis and benefits of the drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
Includes IC50 value and IFN-y fold increase data from patient samples.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The slide uses a three-column layout to highlight the core benefits of the product.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
40
The slide uses two bar charts to illustrate the inverse relationship or trend correlation between volume (clicks) and pricing (CPC) over time.Yelp | Investor Presentation Deck | 42 slides · Yelp
Pitch deck Investor relations Beat · Financials1 hit
42
Includes non-GAAP financial measure disclosure and footnote regarding accounting standards.Yelp | Investor Presentation Deck | 42 slides · Yelp
Pitch deck Investor relations 1 hit